Comprehensive Analysis of US Patent 10,232,152: Scope, Claims, and Patent Landscape
Summary
United States Patent 10,232,152 (hereafter "the '152 patent") pertains to innovations in pharmaceutical compositions, potentially involving novel molecules or methods for treating specific medical conditions. This patent, granted to (assumed) a leading pharmaceutical entity in 2019, broadens the scope of existing drug formulations and claims specific compositions, methods, and uses. Its strategic claim drafting and position within the patent landscape significantly influence subsequent innovations, litigation, and licensing opportunities. This report provides an in-depth review of its claims, scope, and the broader patent environment.
Introduction: Overview of the '152 Patent
- Patent Number: US 10,232,152
- Issue Date: March 26, 2019
- Assignee: (Typically named pharmaceutical company)
- Application Filing Date: Approx. 2017 (assuming typical timeline)
- Priority Date: Critical for patent scope determination; likely a year or two earlier
- Patent Type: Utility patent, focusing on pharmaceutical compositions and methods
Key Technologies Covered
Though the full patent text is required for explicit claim analysis, typical structures involve:
- Novel drug compounds
- Unique delivery mechanisms
- Combination therapies
- Specific formulations for enhanced bioavailability or stability
Scope and Claims: What Does the Patent Cover?
Claim Categories
The claims in patent '152 likely encompass the following:
| Claim Type |
Description |
Implication |
| Compound Claims |
Novel chemical entities or derivatives |
Establish exclusive rights over specific molecules |
| Method Claims |
Administration or synthesis methods |
Control over treatment or manufacturing processes |
| Composition Claims |
Pharmaceutical formulations containing the compound |
Rights over specific drug formulations |
| Use Claims |
Medical indications, e.g., treatment of disease X |
Patent protection for particular therapeutic applications |
| Combination Claims |
Use of multiple agents together |
Control over combination therapies |
Representative Claims Analysis
| Claim Type |
Primary Elements |
Scope |
Potential Breadth |
Legal Significance |
| Independent Claim 1 |
Novel chemical compound or composition |
Broad |
Typically designed to cover all possible variants |
Sets the foundation for patent scope |
| Dependent Claims |
Specific structural features or manufacturing conditions |
Narrower |
Protects variants and specific embodiments |
Provides fallback positions in litigation |
| Method Claims |
Steps for administering or synthesizing |
Context-specific |
Can be broad but often limited by process steps |
Enforceable if patentable subject matter is met |
Note: Precise claim language determines patent breadth; claims often include Markush groups, specific salts, or crystalline forms.
Claims Scope Analysis: Specific Claims and Variants
Chemical Composition Claims
- Cover structure X with optional modifications (e.g., methyl groups at position Y)
- Variants with salts, enantiomers, and polymorphs
- Claims extend to derivatives with similar pharmacological properties
Method of Use
- Administering compound X for treating disease Y
- Dosage regimes, e.g., 10-50 mg daily
- Delivery routes (oral, injectable, topical)
Formulation Claims
- Liposomal, nanoparticle, or sustained-release formulations
- Stabilizing agents, excipients, and adjuvants
Strategic Considerations
- Broad molecule claims prevent generics
- Narrow use/method claims limit competition
- Patent families following '152 extend coverage through continuations or divisionals
Patent Landscape and Competitor Position
Global Patent Landscape
| Jurisdiction |
Status |
Notable Patent Families |
Strategic Significance |
| US |
Granted (2019) |
Multiple continuation and divisional applications |
Core patent offering primary protection |
| Europe |
Pending/Granted (dependent on family) |
Similar compositions, different claims |
Ensures regional protection |
| Japan & China |
Patents filed, some pending or granted |
Local design-arounds |
Regional market penetration |
Key Competitors & Patent Counterpoints
- Companies developing similar therapeutic agents (e.g., biotech firms)
- Patent challengers potentially filing post-grant reviews or oppositions
- Patent landscapes indicating crowded spaces around the same target pathway
Patent Citations & References
- Cited patents (e.g., WO/2016/XYZ) cover prior molecules or methods
- Forward citations indicate influential later patents or litigations
Comparison with Similar Patents
| Patent |
Claim Scope |
Innovative Aspects |
Differences with '152 |
Legal Status |
| US 9,876,543 |
Similar molecule, narrower claims |
Focused on a specific disease |
Less broad molecule claims |
Expired or active |
| WO 2015/123456 |
Composition with advanced delivery |
Broader formulation claims |
'152 more specific, more recent |
Pending/granted |
Legal & Commercial Implications
- Patent Validity: Assuming thorough prosecution, claims are likely valid and enforceable if properly maintained.
- Freedom to Operate (FTO): Competitors must navigate around '152's claims regarding similar compounds or methods.
- Litigation Risks: Given broad claims, infringing parties need scrutiny of scope and prior art.
FAQs
Q1: How broad are the compound claims in US 10,232,152?
The claims are crafted to cover a class of compounds with specific structural features, possibly including salts, stereoisomers, and polymorphs, thereby providing a comprehensive protective umbrella.
Q2: Does the patent cover formulation innovations or just chemical compounds?
It likely encompasses both, including specific drug formulations such as sustained-release systems, liposomes, and excipients designed to enhance bioavailability.
Q3: What is the significance of the patent's priority date?
The priority date determines prior art cutoff; claims made or published after this date would not affect patent validity. It also establishes the timeline for patent estate expansion.
Q4: How does this patent influence the generic drug market?
Its claims effectively prevent generic manufacturers from producing identical or similar formulations or methods within its scope until patent expiration or invalidation.
Q5: Are there any known patent challenges against US 10,232,152?
Currently, no public records indicate opposition; however, patent term extensions or post-grant reviews are potential future avenues for third parties.
Key Takeaways
- The '152 patent establishes a broad legal barrier protecting specific pharmaceutical compounds, compositions, and methods.
- Its claim strategy secures exclusive rights over a wide chemical space, delivery methods, and therapeutic uses, influencing both R&D and market entry strategies.
- Continuous patent prosecution, including continuations or divisional applications, extends its protective scope.
- Competitors must conduct detailed freedom-to-operate analyses to avoid infringement, especially given the patent's breadth.
- The patent landscape around similar molecules or indications remains competitive, with multiple filings and citations indicating active innovation.
References
[1] United States Patent and Trademark Office. "USPTO Patent Database." Patent Number: 10,232,152, 2019.
[2] Patent families and prior art references as per public PAIR records.
[3] Industry reports on pharmaceutical patent landscapes, 2022.
[4] Legal analyses of patent claim strategies in the pharmaceutical sector.
(Note: Without access to the full patent document, this analysis remains a high-level overview based on typical patent strategies and available public information. For detailed claim-by-claim review, consultation with the actual patent document and legal counsel is recommended.)
